Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
Articles
Solid-form development: the key to API success?
The success and effectiveness of an API solid depends on more than just its chemical make-up; the physical properties of the particles that compose the solid, play an equally important role...
COVID-19 vaccine Spikevax approved for children aged 12 to 17 in EU.
EMA's human medicines committee has recommended granting an extension of indication for the COVID-19 vaccine Spikevax to include use in children aged 12 to 17 years.
Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19.
Biocon Biologics announced that U.S. based Adagio Therapeutics has granted an exclusive license to Biocon Biologics to manufacture and commercialize...